Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 46, Issue 2, Pages 723-731
Publisher
SAGE Publications
Online
2017-09-12
DOI
10.1177/0300060517717625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion
- (2016) Mauro Montalbano et al. PLoS One
- Circulating and disseminated tumor cells in ovarian cancer: A systematic review
- (2014) Nuria Romero-Laorden et al. GYNECOLOGIC ONCOLOGY
- Expression of Estrogen Receptor α 36 (ESR36) in the Hamster Ovary throughout the Estrous Cycle: Effects of Gonadotropins
- (2013) Prabuddha Chakraborty et al. PLoS One
- Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
- (2013) Nicolai Juul Birkbak et al. PLoS One
- Stimulation of GPR30 Increases Release of EMMPRIN-Containing Microvesicles in Human Uterine Epithelial Cells
- (2012) Lindsey A. Burnett et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
- (2012) Zuzana Kolkova et al. Journal of Ovarian Research
- GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
- (2012) Satoe Fujiwara et al. Journal of Ovarian Research
- Down-modulation of the G-protein-coupled Estrogen Receptor, GPER, from the Cell Surface Occurs via atrans-Golgi-Proteasome Pathway
- (2011) Shi-Bin Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The G-protein-coupled estrogen receptor GPER in health and disease
- (2011) Eric R. Prossnitz et al. Nature Reviews Endocrinology
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest
- (2010) Q K Y Chan et al. CELL DEATH AND DIFFERENTIATION
- GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
- (2009) Hugo Arias-Pulido et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
- (2009) Yin-Yan He et al. CANCER SCIENCE
- GPR30 predicts poor survival for ovarian cancer
- (2009) Harriet O. Smith et al. GYNECOLOGIC ONCOLOGY
- Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues
- (2009) Georgina G J Hazell et al. JOURNAL OF ENDOCRINOLOGY
- Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish
- (2009) P. Thomas et al. STEROIDS
- Lights and shadows of the tumoral marker CA-125 in ovarian cancer
- (2008) Alfonso Sánchez Muñoz et al. Clinical & Translational Oncology
- G Protein-Coupled Receptor 30 Localizes to the Endoplasmic Reticulum and Is Not Activated by Estradiol
- (2008) Christiane Otto et al. ENDOCRINOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started